In-Vitro Diagnostics for Cardiology and Neurology Market Share

Regionally, the global in-vitro diagnostics for cardiology and neurology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. Asia Pacific industry is set to dominate majority revenue share by 2037, attributed to growing investments by healthcare providers to improve the diagnostics infrastructure in the region. In addition, high need to maintain the rising burden of cardiological diseases is also expected to boost the market growth in the region in the coming years. Moreover, the market in North America is projected to grab the largest share during the forecast period owing to the high healthcare spending, increasing investments to improve molecular diagnostic devices, and strong presence of major market players in the region. As per the data provided by the Centers for Medicare and Medicaid Services, the healthcare spending in the United States grew 9.7 percent in 2020, reaching a value of USD 4.1 trillion or USD 12,530 per person.